Document is current
Any future updates will be listed below
-
Authors
Drygiannakis, Ioannis
Valatas, Vassilis
Filidou, Eirini
Tzenaki, Niki
Archontoulaki, Evangelia
Dovrolis, Nikolas
Kandilogiannakis, Leonidas
Kefalogiannis, Georgios
Sidiropoulos, Prodromos
Kolios, George
Koutroubakis, Ioannis E.
-
Funding
Funding for this research was provided by:
Pfizer Inc. (64132481)
Greek Group for the Study of Inflammatory Bowel Disease (2018, 2018, 2018, 2018, 2018, 2018)
- License Information
-
More Information
Article History
Received: 4 May 2024
Accepted: 6 September 2024
First Online: 25 September 2024
Declarations
:
: The authors have no conflicts of interest to declare.
: All procedures performed involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. The study was recommended for approval by the Bioethics Committee (decision 1599/17–03-2021) and then approved by the Board of Directors (decision 277/07–04-2021) of the hospital the research reported was carried into.
: Informed consent was obtained from all individuals included in the study.
: The authors affirm that human research participants provided informed consent for publication of their anonymized health data.
